Roles
Management
| Name | Role | Total operating income | Total equity | Shares |
|---|---|---|---|---|
G Under liquidation | Managing Director/CEO | 24,395,250 | -27,382,725 | 100 % indirectly |
| Managing Director/CEO | 346,771 | -163,453 | 100 % indirectly | |
| Managing Director/CEO | - | -979,051 | 100 % directly | |
| Managing Director/CEO | - | 30,000 | 36.67 % indirectly |
Boards
| Name | Role | Total operating income | Total equity | Shares |
|---|---|---|---|---|
G Under liquidation | Chairman | 24,395,250 | -27,382,725 | 100 % indirectly |
| Chairman | 346,771 | -163,453 | 100 % indirectly | |
| Chairman | - | -979,051 | 100 % directly | |
| Chairman | - | 30,000 | 36.67 % indirectly | |
| Chairman | - | 23,245 | - | |
G | Chairman | - | 22,195 | - |
Last update: Apr 24, 2023
Related industries
1Direct relationships
2Shares owned by Nikolaos Farmakis
| Name | Share class | Total operating income | Total equity | Share |
|---|---|---|---|---|
Ordinære aksjer | 0 | -979,051 | 100 % directly | |
G Under liquidation | 24,395,250 | -27,382,725 | 100 % indirectly | |
346,771 | -163,453 | 100 % indirectly | ||
0 | 30,000 | 36.67 % indirectly | ||
H Closed | 366,600 | -5,285,825 | 5.1 % indirectly |
Limited to direct ownership positions of 0.5% or more.
Last update: Jun 2, 2025